ARCHIVES

CMS Considering Regulatory Standards for Drug Company Bundling of Products.

This article is from The Cancer Letter archive.

Vol. 32 No. 37 | October 20, 2006

Download PDF Visit The Full Archive

Related Articles

NCAB Committee, NCI Split On Starting New Organ Systems Autodigestive Group

February 15, 1985

Phase III Trial of Avastin and Temozolomide Shows Reduced Risk of Cancer Progression

November 30, 2012

FCRC Recompetition To Be Split Into Two Major Contract, For Research And “Everything Else”

September 5, 1980

ACS Goal To Raise Percentage Of Women Who Get Mammograms

July 31, 1992

HAI Delivery Extends Survival In Patients With Liver Metastasis

March 31, 2006

Elm {15 for 17} Has Some Advice For Would Be CCOPs

July 18, 1986